3D Global Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	133.88	91.7	-57.95	-67.09	-59.71	-47.92
Depreciation & Amortization	25.38	21.82	22.74	25.58	24.59	24.05
Other Amortization	0.06	0.02	0.15	0.29	0.29	0.29
Loss (Gain) From Sale of Assets	-	-0	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	18.89	-	-
Stock-Based Compensation	5.51	4.21	0.12	0.28	0.6	0.52
Provision & Write-off of Bad Debts	0.33	0.21	-	-	-	-
Other Operating Activities	-9.88	3.1	-0.98	-16.08	-1	-0.23
Change in Accounts Receivable	-29.45	-118.41	-0.25	0.14	0.42	0.37
Change in Inventory	5.12	-3.45	-0.23	-2.49	0.26	0.04
Change in Accounts Payable	-38	12.75	1.11	1.56	-0.26	-0.22
Change in Unearned Revenue	2.64	-0.68	5.09	1.51	-	-
Change in Other Net Operating Assets	1.87	8.38	-1.42	2.93	-1.18	-0.12
Operating Cash Flow	97.45	19.65	-31.61	-34.49	-35.99	-23.23
Capital Expenditures	-8.36	-4.74	-0.78	-0.85	-2.86	-0.03
Sale of Property, Plant & Equipment	-	0.05	-	-	-	-
Sale (Purchase) of Intangibles	-0.17	-0.17	-	-0.01	-0.02	-
Investment in Securities	-440.88	-488.54	33.7	19.9	55.5	19.8
Other Investing Activities	-1.39	-1.09	0.66	-0.85	-0.33	-
Investing Cash Flow	-450.8	-494.5	33.58	18.2	52.29	19.77
Long-Term Debt Repaid	-	-6.06	-6.37	-6.25	-4.47	-4.03
Net Debt Issued (Repaid)	-8.91	-6.06	-6.37	-6.25	-4.47	-4.03
Issuance of Common Stock	352.69	517.68	10.69	17.7	-	7.2
Repurchase of Common Stock	-2.37	-2.37	-	-	-	-
Other Financing Activities	-	-0.11	-	-	0.11	-
Financing Cash Flow	341.4	509.15	4.32	11.45	-4.36	3.18
Net Cash Flow	-11.95	34.31	6.29	-4.84	11.94	-0.28
Free Cash Flow	89.09	14.91	-32.39	-35.33	-38.85	-23.26
Free Cash Flow Margin	27.42%	5.61%	-156.99%	-258.98%	-350.81%	-175.38%
Free Cash Flow Per Share	1.13	0.21	-0.58	-0.64	-0.72	-0.43
Cash Interest Paid	0.91	0.12	0.18	0.26	0.26	0.1
Cash Income Tax Paid	0.25	0.09	-0.02	-0.06	-0.05	-0.05
Levered Free Cash Flow	84.19	-24.67	-12.83	-12.85	-16.98	-6.14
Unlevered Free Cash Flow	84.75	-24.59	-12.72	-12.7	-16.82	-6.07
Change in Working Capital	-57.82	-101.41	4.3	3.64	-0.77	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.